{
  "id": "5e46eb7a3f5415952900000d",
  "type": "factoid",
  "question": "Which disease is rated using the Fahn-Tolosa-Marin scale?",
  "ideal_answer": "The Fahn-Tolosa-Marin clinical tremor rating scale is used for essential tremor.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/30045955",
    "http://www.ncbi.nlm.nih.gov/pubmed/29376092",
    "http://www.ncbi.nlm.nih.gov/pubmed/12722174",
    "http://www.ncbi.nlm.nih.gov/pubmed/31974808",
    "http://www.ncbi.nlm.nih.gov/pubmed/28665251",
    "http://www.ncbi.nlm.nih.gov/pubmed/29385927",
    "http://www.ncbi.nlm.nih.gov/pubmed/28326650",
    "http://www.ncbi.nlm.nih.gov/pubmed/30363460",
    "http://www.ncbi.nlm.nih.gov/pubmed/31559624",
    "http://www.ncbi.nlm.nih.gov/pubmed/25247107",
    "http://www.ncbi.nlm.nih.gov/pubmed/29157315",
    "http://www.ncbi.nlm.nih.gov/pubmed/16235669",
    "http://www.ncbi.nlm.nih.gov/pubmed/31868685",
    "http://www.ncbi.nlm.nih.gov/pubmed/31323173",
    "http://www.ncbi.nlm.nih.gov/pubmed/30565036",
    "http://www.ncbi.nlm.nih.gov/pubmed/29777361",
    "http://www.ncbi.nlm.nih.gov/pubmed/10461102",
    "http://www.ncbi.nlm.nih.gov/pubmed/30122598",
    "http://www.ncbi.nlm.nih.gov/pubmed/25527389",
    "http://www.ncbi.nlm.nih.gov/pubmed/29330020",
    "http://www.ncbi.nlm.nih.gov/pubmed/31721077",
    "http://www.ncbi.nlm.nih.gov/pubmed/25471376",
    "http://www.ncbi.nlm.nih.gov/pubmed/30893720",
    "http://www.ncbi.nlm.nih.gov/pubmed/29929813",
    "http://www.ncbi.nlm.nih.gov/pubmed/29530725",
    "http://www.ncbi.nlm.nih.gov/pubmed/29382631",
    "http://www.ncbi.nlm.nih.gov/pubmed/28387629",
    "http://www.ncbi.nlm.nih.gov/pubmed/26982989",
    "http://www.ncbi.nlm.nih.gov/pubmed/17343274",
    "http://www.ncbi.nlm.nih.gov/pubmed/20457958",
    "http://www.ncbi.nlm.nih.gov/pubmed/24038576",
    "http://www.ncbi.nlm.nih.gov/pubmed/29481820",
    "http://www.ncbi.nlm.nih.gov/pubmed/28913163",
    "http://www.ncbi.nlm.nih.gov/pubmed/29293948"
  ],
  "snippets": [
    {
      "text": "The Fahn-Tolosa-Marin (FTM) clinical tremor rating scale was used to score tremor, drawing, and drinking before and after each GKT. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28387629",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Fahn-Tolosa-Marin clinical tremor rating scale was used to evaluate tremor, handwriting, drawing, and drinking.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28665251",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "During each study visit, the Fahn-Tolosa-Marin (FTM) scale, the Unified Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with kinematic assessment of the treated limb. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29157315",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Further, this same network was associated with clinical tremor severity measured with the Fahn, Tolosa, Marin Tremor Rating Scale, suggesting this network is clinically relevant.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29293948",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Results: Postsurgery mean scores for the Fahn-Tolosa-Marin Tremor Scale were improved from 78 to 44 in SCA patients and from 54 to 21 in ET patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29376092",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Secondary objectives include tremor reduction (obtained by the Fahn-Tolosa-Marin tremor rating scale, video recordings, the Unified Parkinson's disease rating scale, and by tremor analysis), psychiatric assessment of patients, and to assess the safety of intervention.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29382631",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "All the enrolled patients were evaluated before the treatment and 2 days after, with a clinical control of the treatment effectiveness using the graphic items of the Fahn-Tolosa-Marin tremor rating scale. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29385927",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Thirty-four ET patients were consecutively enrolled in the experiments and assessed along one year. Arm tremor was videofilmed and scored using the Fahn-Tolosa-Marin Tremor Rating Scale (FTM-TRS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29481820",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fahn-Tolosa-Marin tremor rating scale was used for tremor evaluation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29530725",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Tremor and cerebellar signs were scored according to the Fahn-Tolosa-Marin and the SARA scale.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29777361",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Tremor severity on acute stimulation was assessed by the Fahn-Tolosa-Marin Tremor Rating Scale. Cerebellar impairment was evaluated with the International Cooperative Ataxia Rating Scale. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30045955",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The treatment efficacy was evaluated by the Fahn Tolosa Marin tremor rating score and NIH genetic criteria for tremor severity at 4 and 8 weeks after each of the two sets of treatments. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29929813",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Two neurologists rated ET by Fahn-Tolosa Marin Tremor Rating Scale (FTMTRS). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30122598",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "JECTIVE: To compare the sensitivity of the Fahn-Tolosa-Marin Tremor Rating Scale, the Part III of the Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and the MDS-UPDRS Tremor Scale to the effects of various antitremor treatments.ME",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31868685",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "r functions were rated prior to and after surgery using the revised Unified Parkinson's Disease Rating Scale part III (MDS-UPDRS-III), the Fahn-Tolosa-Marin Tremor-Rating-Scale (FTM-TRS), and the Unified Dystonia Rating Scale (UDRS). Fur",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31323173",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " MEASURES: Clinical outcomes, as measured by the Fahn-Tolosa-Marin Tremor Rating Scale and activities of daily living scores, and incidence of adverse events.RESULTS: Fro",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20457958",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "[Validation study of the Spanish version of the Fahn-Tolosa-Marin scale for essential tremor].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31559624",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "INTRODUCTION: The Fahn-Tolosa-Marin (FTM) tremor rating scale has been widely used in clinics for the estimation of tremor severity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31559624",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "a-Marin Tremor Rating Scale activities of daily living scores improved significantly after GKT (P = .03; median and mean change scores, 2.5 and 2.7 points, respectively [range of scale was 0-27]), but there was no significant improvement in other Fahn-Tolosa-Marin Tremor Rating Scale items (P = .53 for resting tremor, P = .24 for postural tremor, P = .62 for action tremor, P = .40 for drawing, P > .99 for pouring water, P = .89 for head tremor). Handwriting a",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20457958",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "inical outcomes were assessed using the Fahn-Tolosa-Marin tremor rating scale at baseline and postoperatively at the time of evaluation. T",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28326650",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "S: Part B of the Fahn-Tolosa-Marin Tremor Rating Scale was the most sensitive to acute levodopa challenge (Cohen's d\u200a=\u200a-1.04, \u03b72\u200a=\u200a0.12). Howev",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31868685",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "emor severity was recorded using the Fahn-Tolosa-Marin Tremor Rating Scale and/or the Unified Parkinson's Disease Rating Scale.RE",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29330020",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "THODS: Clinical outcomes were evaluated in 19 patients who had undergone DBS surgery by using the Fahn-Tolosa-Marin clinical tremor rating scale. A",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16235669",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "and after surgery, PD patients were evaluated using the Unified PD Rating Scale (UPDRS), and ET patients were evaluated using the Fahn-Tolosa-Marin (FTM) tremor rating scale. Inner and to",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10461102",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ter blinded to treatment evaluated Unified Parkinson's Disease Rating Scale, Fahn-Tolosa-Marin Tremor Rating Scale, Nonmotor Symptoms Assessment Scale, and a structured questionnaire on ropinirole side effects. Besides, ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25247107",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "e studied a cohort of 125 consecutive patients treated with valproate due to epilepsy or migraine, evaluated with the Fahn-Tolosa-Marin Tremor Rating Scale (FTM-TRS). A to",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31721077",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "was evaluated using the Fahn-Tolosa-Marin tremor rating scale (FTM-TRS) in ET patients. The patients wi",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25527389",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " was assessed using the Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS) and the Lower Extremity Clinical Tremor Assessment Scale (LECTAS). A significant diffe",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30565036",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " evaluated using the Fahn-Tolosa-Marin Tremor Rating Scale. Poor sleep quality,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25471376",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "rity was assessed using the Fahn-Tolosa-Marin tremor rating scale (FTM-TRS) and tremor amplitude and frequency were evaluated using kinematic techniques. Cognitive prof",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31974808",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "sessments included global improvement, Fahn Tolosa Marin Tremor Rating Scale, Beck Depression Inventory and the Parkinson's Disease Questionnaire-39. Patient globa",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12722174",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "tients. Methods: The clinical and imaging data of HT patients in 5 teaching hospitals between January 2014 and January 2018 were retrospectively analyzed, and Fahn-Tolosa-Marin Tremor Rating Scale (TRS) was used to compare the clinical severity and short-term prognosis between the differen",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30893720",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " and all the other brain areas. These measures were then correlated with the tremor severity evaluated by the Fahn-Tolosa-Marin",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28913163",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "o compare the sensitivity of the Fahn-Tolosa-Marin Tremor Rating Scale, the Part III of the Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and the MDS-UPDRS Tremor Scale to the effects of various antitremor treatments.ME",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31868685",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "t B of the Fahn-Tolosa-Marin Tremor Rating Scale was the most sensitive to acute levodopa challenge (Cohen's d\u200a=\u200a-1.04, \u03b72\u200a=\u200a0.12). Ho",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31868685",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ever, Part A of the Fahn-Tolosa-Marin Tremor Rating Scale showed the highest effect size, which was a small one (Cohen's d\u200a=\u200a-0.33, \u03b72\u200a=\u200a0.03), for detecting a treatment-related change in the severity of tremor during long-term follow-up.CONC",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31868685",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background: The Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low for patients with severe tremor (tremor amplitude >4 c",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30363460",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Before and after surgery, PD patients were evaluated using the Unified PD Rating Scale (UPDRS), and ET patients were evaluated using the Fahn-Tolosa-Marin (FTM) tremor rating scale.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10461102",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Tremor rate was evaluated using the Fahn-Tolosa-Marin tremor rating scale (FTM-TRS) in ET patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25527389",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Methods: The clinical and imaging data of HT patients in 5 teaching hospitals between January 2014 and January 2018 were retrospectively analyzed, and Fahn-Tolosa-Marin Tremor Rating Scale (TRS) was used to compare the clinical severity and short-term prognosis between the different subtypes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30893720",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: The Fahn-Tolosa-Marin (FTM) tremor rating scale has been widely used in clinics for the estimation of tr",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31559624",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Five tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor Rating Assessment Scale), one ADL/disability scale (the Bain and Findley Tremor ADL Scale), one quality-of-life scale (the Quality of Life in Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor Rating Scale, version 1) are recommended using these criteria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24038576",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "All participants were assessed using the Fahn-Tolosa-Marin Tremor Rating Scale for the severity of tremor; a neuropsychological assessment battery and a screening questionnaire for mood and anxiety symptoms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26982989",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The purpose of this study was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor (ET).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17343274",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17343274",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Comparison of the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor Rating Assessment Scale.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30363460",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "essential tremor"
}